National Research (NASDAQ:NRC) Stock Crosses Above 200 Day Moving Average – What’s Next?

Shares of National Research Corporation (NASDAQ:NRCGet Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $15.98 and traded as high as $17.59. National Research shares last traded at $17.34, with a volume of 60,208 shares.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings lowered shares of National Research from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, March 6th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.

Check Out Our Latest Analysis on National Research

National Research Price Performance

The business’s 50 day moving average is $15.94 and its 200 day moving average is $15.99. The company has a quick ratio of 0.55, a current ratio of 0.55 and a debt-to-equity ratio of 5.36. The company has a market cap of $390.39 million, a P/E ratio of 34.32 and a beta of 0.39.

National Research (NASDAQ:NRCGet Free Report) last announced its earnings results on Tuesday, February 3rd. The company reported $0.16 earnings per share (EPS) for the quarter. National Research had a return on equity of 103.84% and a net margin of 8.44%.The business had revenue of $35.19 million for the quarter.

National Research Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 10th. Investors of record on Friday, March 27th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 27th. This represents a $0.64 dividend on an annualized basis and a yield of 3.7%. National Research’s dividend payout ratio (DPR) is presently 128.00%.

Institutional Trading of National Research

Institutional investors have recently modified their holdings of the company. Hotchkis & Wiley Capital Management LLC raised its stake in shares of National Research by 7.9% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 292,400 shares of the company’s stock worth $3,737,000 after acquiring an additional 21,450 shares in the last quarter. AQR Capital Management LLC boosted its stake in National Research by 86.2% in the second quarter. AQR Capital Management LLC now owns 201,396 shares of the company’s stock valued at $3,383,000 after acquiring an additional 93,262 shares in the last quarter. Willis Investment Counsel grew its holdings in National Research by 1.6% in the fourth quarter. Willis Investment Counsel now owns 183,226 shares of the company’s stock worth $3,439,000 after purchasing an additional 2,920 shares during the last quarter. Bank of America Corp DE grew its holdings in National Research by 5.8% in the second quarter. Bank of America Corp DE now owns 122,344 shares of the company’s stock worth $2,055,000 after purchasing an additional 6,690 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in shares of National Research by 18.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 114,967 shares of the company’s stock worth $2,158,000 after purchasing an additional 18,067 shares in the last quarter. 47.26% of the stock is currently owned by institutional investors.

National Research Company Profile

(Get Free Report)

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.

Read More

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.